http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007001818-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_831fb22d79357ca39f4b07cc0156c863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2150942a106a01671eb30888d21e35b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b96cc1b38aad30c7997eba0e74e63bdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_790e69f202d30702312797a3deaa6eb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3546e17f2a9cba254b0b7775a889dd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_244196dc536fae48c044ff395608cb0c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-08
filingDate 2006-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4ea1264a15e0cdea0eca694871c4605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c26ebe40f157a11c1653ca00def4f7e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bac7c1ce852dcf05e8de77a1c8425122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3790f144b5a39b0ec6e75809effd145f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fe349812e68d79dbcf1373a2e76227a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74f02076ec0dbebec3d410244cd0962b
publicationDate 2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007001818-A3
titleOfInvention Substituted isoindole-1,3-diones
abstract The present invention relates to substituted isoindole-1,3-dione compounds of Formula (I) and pharmaceutically acceptable forms thereof, as α1a/α1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as methods of treatment.
priorityDate 2005-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009398
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID539543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393258
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID472723
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11549
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29412
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID428203
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID148
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11550
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID469869
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID422933
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID552897
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID568614
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID111092035
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID798498
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID146
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549912
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403866
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6809
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135474

Total number of triples: 48.